Grasim Industries Nomination and Remuneration Committee Approves Stock-Based Incentive Grant

Grasim Industries Limited has announced the grant of 28,001 stock-based incentives to its eligible employees. This allocation, approved by the Nomination and Remuneration Committee on May 4, 2026, includes 18,722 stock options and 9,279 performance stock units. The initiative is part of the company’s 2022 employee benefit scheme, designed to align workforce performance with long-term organizational goals and internal performance benchmarks.

Grant Distribution Overview

The total grant of 28,001 units is split between traditional stock options and performance-linked instruments. Eligible employees have been issued 18,722 stock options, while 9,279 performance stock units (PSUs) were awarded to foster a culture of ownership and high performance. These instruments are facilitated through the company’s dedicated employees’ welfare trust.

Vesting and Exercise Terms

The vesting schedule is tailored to both retention and performance milestones. For the 18,722 stock options, the vesting follows a phased approach, with 33% becoming available annually over a 3-year period, starting one year from the grant date. In contrast, the 9,279 PSUs are subject to a 100% cliff-vesting mechanism at the end of the 3-year tenure. Once vested, all employees have a window of 5 years to exercise their options.

Pricing and Performance Conditions

The exercise price for the stock options has been fixed at Rs. 2,794.50 per option, calculated based on the market price as of April 30, 2026. The PSUs have been granted at a nominal value of Rs. 2 per unit. Notably, the vesting of all these incentives is strictly tied to performance conditions outlined in the scheme documentation, ensuring that the grants are effectively linked to the company’s ongoing success and individual employee contributions.

Source: BSE

Previous Article

Cigniti Technologies Scheme of Amalgamation with Coforge Becomes Effective

Next Article

Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid